ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
20 announcements
Amwill Health Care committed ₹3 Crore to Nippon India Credit Opportunities AIF Scheme II. The investment, funded from internal accruals, is drawn down in tranches.
Amwill Health Care's board declared an interim dividend of Rs.0.05 per equity share for FY 2026-27 on 23 October 2026. The record date is 30 October 2026 and payment is proposed by 22 November 2026.
Amwill Health Care Ltd reported revenue from operations of ₹22.6 Cr (-7.0% YoY) and net profit of ₹3.7 Cr (-50.7% YoY) for H1 FY27.
Amwill Health Care has scheduled a board meeting for October 23, 2026, to review H1 financial results and consider declaring an interim dividend.
This filing is a standard quarterly Shareholding Pattern submission in accordance with SEBI Regulation 31(1)(b) for Amwill Health Care Ltd as of September 30, 2026.
Amwill Health Care received an import license from CDSCO for FoliColor hair products, enabling the company to commence commercial sale and import into India.
Amwill Health Care Limited approved investments of ₹3 Crore into two Alternative Investment Funds. The company will invest ₹1.50 Crore each in Vivriti Vihaan Trust and Neo Income Plus Fund III.
Amwill Health Care Ltd re-appointed Mr. Tarun Gandhi and Mr. Anand Gandhi as Managing Directors for a five-year term, effective January 27, 2027.
Amwill Health Care Limited conducted its 9th Annual General Meeting on August 14, 2026, to discuss the business items listed in the meeting notice.
Amwill Health Care Ltd announced a new treasury strategy, approving aggregate investment limits totaling ₹33 Crore across debt, equity, and mutual fund segments for surplus capital.
Amwill Health Care Ltd approved the re-appointment of Mr. Tarun Gandhi and Mr. Anand Gandhi as Managing Directors. The Board also scheduled the upcoming 09th AGM.
Amwill Health Care has approved the opening of a ₹2 Crore fixed deposit with Vysya Co-operative Bank, funded through its internal accruals.
Amwill Health Care Limited has issued a notice for its 9th Annual General Meeting, scheduled for August 14, 2026, to transact ordinary and special business.
Amwill Health Care Limited recommended a final dividend of 5% for the financial year 2025-26. The record date is set for August 8, 2026.
Amwill Health Care re-appointed Mr. Tarun Gandhi and Mr. Anand Gandhi as Managing Directors for five years. The Board also convened the 9th AGM for August 14, 2026.
Amwill Health Care Ltd reported revenue from operations of ₹24.3 Cr (+39.7% YoY) and net profit of ₹7.5 Cr (+78.6% YoY) for H2 FY26.
Amwill Health Care approved FY26 audited financial results and recommended a ₹0.50 per share final dividend. Annual revenue reached ₹45.49 Crore with a net profit of ₹11.42 Crore.
Amwill Health Care declared non-applicability of the Annual Secretarial Compliance Report for FY26. As a BSE SME entity, it is exempt under Regulation 15(2).
Amwill Health Care scheduled a board meeting for May 30, 2026. Directors will consider FY26 audited financial results and recommend a final dividend.
Amwill Health Care Ltd provided an update regarding a February 2026 cyber security incident that caused data loss in its Structured Digital Database. The company has reconstructed and re-entered all required UPSI entries from July 2025 onwards, as confirmed by a professional certificate from a Company Secretary.